Hangzhou Proserre Chemistry Co., Ltd., established in 2013, is an integrated industrial and trading enterprise from China engaged in pharmaceutical APIs, intermediate products, and drug registration services. We serve global customers by providing high-quality new drug products and contract manufacturing solutions through our market-driven R&D and production integration.

Presently, our core CRAMs/CDMO business segment is supported by:

1. R&D Center: A dedicated research and development center with approximately 40 professional R&D staff, focused on cutting-edge technology and dosage form studies.

2. Manufacturing Sites: We have five collaborative production sites (including two major sites covering 110,000 sq meters and 100,000 sq meters respectively). Our sites have passed audits for advanced intermediates and APIs from authorities such as PMDA and NMPA (SFDA). Furthermore, they consistently pass frequent EHS & Quality audits from global pharmaceutical leaders, including Pfizer, Novartis, J&J, Astellas, and Daiichi Sankyo.

Our product range covers Generic compounds (including their intermediates) and Innovative compounds. Most of our staff possess rich industry experience, and our operations strictly follow standardized SOPs.

With a national AAAA-level credit rating certification, our common purpose is to be one of the most professional and reliable integrated pharmaceutical groups in China, dedicated to delivering value contribution and win-win cooperation for our global clients in the fine pharmaceutical area.